Global Vascular Imaging Market Outlook
Revenue, 2024
$2.8B
Forecast, 2034
$5.8B
CAGR, 2025 - 2034
7.6%
The Vascular Imaging industry revenue is expected to be around $3.0 billion in 2025 and expected to showcase growth with 7.6% CAGR between 2025 and 2034. The rise of vascular diseases and the aging of the population increase the need for Vascular Imaging. The shift toward invasive image guided interventions and non invasive diagnostics also raises the demand for Vascular Imaging. Hospitals and diagnostic imaging centers together account for 84.4% of end user demand. The large share shows that advanced imaging suites, radiology labs that perform interventions and vascular teams, from specialties are mainly found in hospitals and diagnostic imaging centers. On the supply side, systems & consoles remain the backbone of the market, with this product category generating approximately $1.63 billion in revenue in 2024, underpinned by continuous upgrades in CT angiography, MR angiography, and duplex ultrasound platforms that deliver higher spatial resolution, lower radiation dose, and faster workflow across diagnostic imaging services.
The clinical and technological aspects of Vascular Imaging use CT angiography and MR angiography and duplex and color Doppler ultrasound and digital subtraction angiography to show blood flow in real time while examining vessel walls and atherosclerotic plaque characteristics. The medical field uses these imaging technologies to diagnose coronary and peripheral artery diseases and to evaluate carotid and cerebral blood vessels for stroke prevention and to detect aortic aneurysms and hemodialysis access problems and deep vein thrombosis and to guide complex endovascular procedures. The market demand for Vascular Imaging technology increases because of three main factors which include AI and ML based vessel segmentation and quantification and hybrid operating room expansion and point of care vascular ultrasound adoption. The combination of new technologies has improved medical diagnosis while making treatment plans more individualized for patients with high cardiovascular and peripheral vascular risks who receive Vascular Imaging at hospitals and diagnostic centers.
Market Key Insights
The Vascular Imaging market will expand from $2.8 billion in 2024 to $5.8 billion during the period from 2024 to 2034. The market will expand at a 7.6% annual rate because of increasing requirements for Atherosclerosis Assessment and Aneurysm Monitoring and Deep Vein Thrombosis diagnosis.
Siemens Healthineers, GE Healthcare, and Fujifilm are among the leading players in this market, shaping its competitive landscape.
U.S. and China are the top markets within the Vascular Imaging market and are expected to observe the growth CAGR of 4.9% to 7.3% between 2024 and 2030.
The market research predicts that India, Brazil and South Korea will experience the highest growth rates at 8.7% to 10.5% CAGR.
Transition like AI-Enabled Precision Imaging is expected to add $358 million to the Vascular Imaging market growth by 2030
.The Vascular Imaging market will experience $3.0 billion growth during 2024-2034 because manufacturers will focus on developing products for Aneurysm & Vasculitis Application.
With
escalating cardiovascular disease burden and shift to minimally invasive diagnostics driving demand for advanced vascular imaging, and
AI-enabled image analysis and workflow automation significantly enhancing efficiency and diagnostic accuracy in vascular imaging, Vascular Imaging market to expand 108% between 2024 and 2034.
Opportunities in the Vascular Imaging
The European healthcare sector requires advanced Vascular Imaging systems for hybrid operating rooms because endovascular procedures for stroke and aortic disease and critical limb ischemia continue to increase. The majority of mid sized interventional radiology centers operate with outdated fluoroscopy consoles because they maintain restricted disposable stock levels. The global market for accessories and consumables will also expand from 0.90 billion in 2024 to 1.49 billion by 2030 at an 8.7% annual growth rate. The market for intraoperative Vascular Imaging consumables will experience the highest expansion because of new contrast agents and single use catheters designed for complex peripheral interventions.
Growth Opportunities in North America and Asia-Pacific
The North American Vascular Imaging market depends on large tertiary hospitals because they perform the most procedures in interventional radiology and complex cardiovascular imaging while diagnostic imaging centers show the fastest growth for outpatient vascular ultrasound and CT angiography and MR angiography services; the market offers three main opportunities to expand advanced vascular diagnostics into community hospitals and create integrated image guided therapy pathways with ambulatory surgery centers for endovascular procedures and to implement AI driven workflow optimization for faster reporting and better acute stroke and peripheral artery disease case management. The market competition exists between vendors who offer different technological solutions and maintain strong service agreements and provide complete software solutions that work well with current hospital information systems. The three main factors that drive regional market growth stem from high cardiovascular disease rates and solid non invasive Vascular Imaging payment systems and medical guidelines that require early detection of vascular conditions in at risk groups.
The Vascular Imaging market in Asia Pacific depends heavily on large urban hospitals which perform most high acuity vascular diagnostic procedures but diagnostic imaging centers now show increasing strategic importance because health systems are moving services to decentralized locations and want affordable vascular ultrasound and CT angiography and MR angiography access in expanding metropolitan and secondary cities; the market requires mid range Vascular Imaging solutions which fit public hospital budgets while private diagnostic imaging chains need standardized Vascular Imaging protocols and teleradiology support for their expansion into ambulatory surgery centers for endovascular interventions; the market competition intensifies between international manufacturers and regional players who battle for market share through price competition and reliable service delivery and local network presence. The market expansion is driven by three main factors which include diabetes and hypertension prevalence growth and government funding for imaging facilities and healthcare insurance expansion and medical professionals increasing emphasis on stroke and peripheral artery disease early detection to minimize future healthcare expenses.
Market Dynamics and Supply Chain
01
Driver: Escalating cardiovascular disease burden and shift to minimally invasive diagnostics driving demand for advanced Vascular Imaging
The increasing number of patients with coronary artery disease and stroke and peripheral artery disease requires healthcare providers to build up Vascular Imaging capabilities throughout hospitals and outpatient facilities. The growing number of patients at high risk for cardiovascular disease requires imaging based diagnostics according to new clinical guidelines which also drives investments in high resolution ultrasound and CT angiography and MR angiography systems. The increasing number of patients with cardiovascular disease also receives support from two factors doctors now perform more non invasive imaging procedures and endovascular treatments which need precise vessel mapping and real time perfusion assessment. The expansion of endovascular treatments requires Vascular Imaging for both pre procedure access route planning and stent size selection and post procedure patency assessment which decreases the need for traditional catheter angiography. The combination of these trends also drives healthcare organizations to purchase new imaging technologies and develop standardized protocols for multi modal imaging which establishes advanced Vascular Imaging as the essential component of contemporary cardiovascular treatment plans and ongoing disease management.
The fast adoption of AI based reconstruction and segmentation and quantification tools has also revolutionized radiologist interpretation of complex vascular studies. The combination of automated stenosis and aneurysm and thrombus detection with standardized reporting templates enables faster reading times and better measurement consistency. The integration of AI technology within CT angiography and MR angiography suites enables better image quality at reduced radiation exposure and contrast agent usage which expands diagnostic possibilities for vulnerable patients. The end to end workflow management system enables Vascular Imaging departments to process increasing study numbers by reducing backlogs and providing quick and reliable diagnostic results.
02
Restraint: High capital costs and infrastructure requirements limit adoption of advanced Vascular Imaging systems across facilities
The high initial costs for MRI and CT angiography and hybrid non invasive imaging suites for Vascular Imaging prevent smaller hospitals and outpatient centers from acquiring new equipment which results in delayed purchases and reduced vendor profitability. The delayed equipment purchases lead to increased demand for refurbished diagnostic imaging systems and basic ultrasound platforms and shared service solutions which reduces premium segment revenue even though cardiovascular disease screening programs continue to grow.
03
Opportunity: Expanding cardiovascular screening programs in aging North American populations drive demand for advanced Vascular Imaging and Adoption of AI driven Vascular Imaging software in tertiary hospitals across Asia Pacific accelerates precision diagnostics
The United States and Canada use Vascular Imaging to identify cardiovascular risks in their populations while diabetes and hypertension and peripheral artery disease screening programs continue to expand. The integration of duplex ultrasound and CT angiography into primary care and retail clinics becomes possible through tele radiology networks. The market value of systems and consoles reached 1.63 billion dollars in 2024 and experts predict it will grow to 2.33 billion dollars by 2030 at a 6.1% annual rate but these technologies have not only reached enough community healthcare facilities. The market will experience its highest expansion through non invasive ultrasound based Vascular Imaging systems which will be used in outpatient facilities.
The Asia Pacific region sees increasing demand for AI based Vascular Imaging software which performs automated plaque measurement and vessel boundary detection and three dimensional image construction. The current use of outdated workstations in institutions creates an opportunity for cloud based systems which enable data exchange between different systems. The software and services market will expand from 0.26 billion in 2024 to 0.52 billion by 2030 at a 12.19% annual growth rate which positions it as the markets fastest growing segment. The fastest market growth will occur through advanced MR angiography and CT angiography post processing solutions which will be adopted by urban hospital networks.
04
Challenge: Shortage of skilled technologists and specialists constrains Vascular Imaging capacity and undermines diagnostic service quality
The shortage of trained radiologists and vascular sonographers and interventional cardiologists leads to extended waiting periods for Vascular Imaging tests which reduces procedure numbers and leaves hospital radiology departments with underused high end angiography and CT and MRI systems.
Supply Chain Landscape
1
Digital Radiography Components
Shimadzu CorporationFujifilm Corporation
2
Vascular Imaging Systems
Siemens HealthineersGE HealthcarePhilips Healthcare
3
Diagnostic Imaging Software
Siemens HealthineersGE HealthcareFujifilm Corporation
4
Clinical End Users
HospitalsInterventional Radiology CentersAngiography Suites
1
Digital Radiography Components
Shimadzu CorporationFujifilm Corporation
2
Vascular Imaging Systems
Siemens HealthineersGE HealthcarePhilips Healthcare
3
Diagnostic Imaging Software
Siemens HealthineersGE HealthcareFujifilm Corporation
4
Clinical End Users
HospitalsInterventional Radiology CentersAngiography Suites
Use Cases of Vascular Imaging in Atherosclerosis Assessment & Deep Vein Thrombosis
Atherosclerosis Assessment : The main focus of Vascular Imaging in atherosclerosis involves non invasive Doppler ultrasound for carotid and peripheral vascular disease assessment while CT angiography and MR angiography help measure plaque amount and track vessel changes to support radiology interventions for patients at high risk. The majority of complex cardiovascular imaging procedures occur at hospitals which generated 1.73 billion in Vascular Imaging revenue during 2024 and expect to expand at 7.3% CAGR until 2030. The main focus of diagnostic imaging centers lies in performing high volume outpatient assessments and long term risk evaluation through their 0.64 billion revenue stream with 8.1% annual growth. The market requires Systems & Consoles to meet 58.3% of its needs because accurate lumen and plaque visualization depends on high end scanners and angiography suites which receive support from Accessories & Consumables at 32.3% and Software & Services at 9.40% for automated quantification and risk scoring. Siemens Healthineers and GE Healthcare dominate this market through their complete range of CT and MRI and ultrasound solutions for atherosclerotic cardiovascular imaging. Philips Healthcare stands out through its hybrid operating room image guided therapy systems which integrate with other medical equipment. Fujifilm Corporation and Shimadzu Corporation enhance their market presence through their advanced ultrasound systems and digital subtraction angiography solutions which focus on vascular medical applications.
Aneurysm Monitoring : The main Vascular Imaging method for intracranial and aortic aneurysm monitoring consists of high resolution CT angiography and MR angiography which detect small lesions and evaluate neck morphology and perform serial neurovascular imaging follow up until digital subtraction angiography becomes necessary for complex cases and endovascular planning. The main location for aneurysm treatment occurs in hospitals because they provide both emergency stroke services and advanced angiography facilities and they maintain the highest investment in systems & consoles which amounts to 58.3% of total demand. The systems & consoles at hospitals enable fast protocol based assessments and immediate surgical interventions during high risk rupture situations through their combination with Accessories & Consumables and specialized Software & Services for 3D modeling and device sizing. The application benefits from Philips Healthcares leading position because their integrated cath lab and hybrid operating room systems optimize cerebrovascular and aortic repair procedures. Siemens Healthineers and GE Healthcare maintain strong competition through their wide range of biplane angiography systems and cross sectional imaging platforms. Shimadzu Corporation maintains its position as a leading provider of reliable angiography rooms for high volume centers while Fujifilm Corporation expands its market presence through adaptable CT and MRI systems that support complete stroke and aneurysm treatment protocols.
Deep Vein Thrombosis : The main Vascular Imaging method for deep vein thrombosis diagnosis involves ultrasound tests which perform real time compression and flow assessment to verify blood clots and show clot size and treatment effectiveness but CT or MRI with contrast enhancement serves for complex pelvic and abdominal venous obstruction assessment and intravascular ultrasound helps guide catheter directed thrombolysis and stenting procedures. The 0.64 billion Vascular Imaging revenue from diagnostic imaging centers in 2024 will expand at 8.1% CAGR until 2024 while ambulatory surgery centers will reach 0.32 billion with 9.3% annual growth through their adoption of minimally invasive venous interventions using compact systems & consoles and their need for Accessories & Consumables. The market competition for this application remains intense between GE Healthcare and Siemens Healthineers because they provide extensive ultrasound products for venous flow imaging and point of care solutions. Philips Healthcare expands its market share through its integrated reporting and workflow software which enables cardiovascular imaging to link with anticoagulation management systems. Fujifilm Corporation and Shimadzu Corporation maintain market diversity through their affordable and powerful ultrasound and fluoroscopy systems which appeal to hospitals and ambulatory centers operating with value based strategies.
Recent Developments
The current advancements in Vascular Imaging stem from non invasive imaging breakthroughs and hybrid imaging platforms and AI based diagnostic tools which improve vascular disease identification and clinical workflow management. The increasing use of CT angiography and MR angiography and portable ultrasound technology enables better access to peripheral Vascular Imaging and cardiovascular imaging throughout outpatient facilities and point of care locations.
February 2023 : GE HealthCare has reached a final agreement to purchase Caption Health which will merge AI powered ultrasound technology into their cardiovascular and Vascular Imaging solutions to enhance automated vascular ultrasound testing and expand hospital and outpatient clinic access to high quality Doppler ultrasound diagnostics.
January 2023 : The spin off of GE HealthCare from General Electric created an independent company which enables focused capital distribution for advanced Vascular Imaging technologies including CT angiography and MR angiography and interventional radiology angiography systems to drive faster worldwide product development and market penetration.
Impact of Industry Transitions on the Vascular Imaging Market
As a core segment of the Medical Device industry,
the Vascular Imaging market develops in line with broader industry shifts.
Over recent years, transitions such as AI Enabled Precision Imaging and Migration To Outpatient Care have redefined priorities
across the Medical Device sector,
influencing how the Vascular Imaging market evolves in terms of demand, applications and competitive dynamics.
These transitions highlight the structural changes shaping long-term growth opportunities.
01
AI Enabled Precision Imaging
The integration of AI technology in Vascular Imaging is revolutionizing the landscape by enabling precise measurements of plaque, blood flow patterns, and aneurysm susceptibility during real time imaging. This transition enhances acute stroke assessments and automates CT and MR angiography analysis, significantly improving the precision of endovascular treatments. As healthcare providers increasingly adopt ML analytics from equipment vendors and digital health platforms, operational efficiencies and competitive dynamics between hospitals and outpatient facilities are being transformed. This strategic shift is projected to contribute an impressive $356 million to the Vascular Imaging market by 2030, underscoring the critical role of AI enabled precision imaging in driving market growth and enhancing patient outcomes. This industry transition is expected to add $358 million in the industry revenue between 2024 and 2030.
02
Migration To Outpatient Care
The healthcare industry now uses Vascular Imaging outside hospital catheter labs because non invasive imaging technologies including Doppler ultrasound and CT angiography and MR angiography have become available for outpatient and ambulatory center use. The new approach decreases healthcare expenses while shortening patient hospital stays for treating peripheral artery disease and deep vein thrombosis and carotid artery screening which benefits cardiology and oncology and vascular surgery departments. The healthcare industry now works to create new treatment routes through investments in small medical devices and payment systems that support immediate image based procedures.